Supplemental material
Journal of Medical Economics
Volume 23, 2020 - Issue 8
Open access
1,835
Views
5
CrossRef citations to date
0
Altmetric
Health Policy
The fiscal consequences of public health investments in disease-modifying therapies for the treatment of multiple sclerosis in Sweden
Nikolaos KotsopoulosHealth Economics, Global Market Access Solutions Sarl, St-Prex, Switzerland; ;Department of Economics, University of Athens, Athens, Greece;
, Mark P. ConnollyHealth Economics, Global Market Access Solutions Sarl, St-Prex, Switzerland; ;Unit of Pharmacoepidemiology & Pharmacoeconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands; Correspondence[email protected] [email protected]
http://orcid.org/0000-0002-1886-745X
, http://orcid.org/0000-0002-1886-745X
Thibaut DortGlobal Value & Access, Biogen International GmbH, Baar, Switzerland;
& Andrius KavaliunasDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Pages 831-837
|
Received 07 Feb 2020, Accepted 01 Apr 2020, Published online: 13 May 2020
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.